Related references
Note: Only part of the references are listed.A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine
Tomas M. Murdych
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2022)
Autoimmune Hemolytic Anemias
Sigbjorn Berentsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease
Lucia Perez-Lamas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2021)
Simultaneous onset of COVID-19 and autoimmune haemolytic anaemia
Chris Lopez et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Autoimmune haemolytic anaemia associated with COVID-19 infection
Gregory Lazarian et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
COVID-19 infection associated with autoimmune hemolytic anemia
Antoine Capes et al.
ANNALS OF HEMATOLOGY (2020)
The Changing Landscape of Autoimmune Hemolytic Anemia
Wilma Barcellini et al.
FRONTIERS IN IMMUNOLOGY (2020)
Severe Autoimmune Hemolytic Anemia in COVID-19 Infection, Safely Treated with Steroids
Fehmi Hindilerden et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES (2020)
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Jia Yu et al.
BLOOD (2020)
Efficacy of eculizumab in refractory life-threatening warm autoimmune hemolytic anemia associated with chronic myelomonocytic leukemia
Anne-Cecile Gauchy et al.
CLINICAL CASE REPORTS (2020)
Eculizumab and Beyond: The Past, Present, and Future of Complement Therapeutics
Christopher J. Patriquin et al.
TRANSFUSION MEDICINE REVIEWS (2019)
The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
Pavan K. Bendapudi et al.
LANCET HAEMATOLOGY (2017)
Refractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy
Kim Ma et al.
CASE REPORTS IN HEMATOLOGY (2016)
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
W. Barcellini et al.
DISEASE MARKERS (2015)
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Wilma Barcellini
TRANSFUSION MEDICINE AND HEMOTHERAPY (2015)
Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy
Sigbjorn Berentsen et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Refractory warm IgM-mediated autoimmune hemolytic anemia associated with Churg-Strauss syndrome responsive to eculizumab and rituximab
Mark P. Chao et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini et al.
BLOOD (2014)
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic-Uremic Syndrome
C. M. Legendre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
Peter Hillmen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin - A novel mechanism of human disease
RP Rother et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Share Paper
